Naomi Watts wants women to own menopause story: 'Why is it so taboo when we are half the population?'

1 day ago

Trump nominates Erica Schwartz as CDC director

3 days ago

Here's our monthly update on all 31 portfolio stocks, including 3 on the buy list

3 days ago

RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves

3 days ago

Novo Nordisk partners with OpenAI as AI drug discovery hopes mount

5 days ago

Revolution Medicines says its pancreatic cancer drug succeeds in late-stage trial

5 days ago

A mom tech entrepreneur building AI advocate for rare-disease families like hers

6 days ago

Trump policies, China's biotech boom are ending Europe's pharma powerhouse era

8 days ago

Former senator shines spotlight on a possible breakthrough for pancreatic cancer

8 days ago

CNBC Cures: A doctor dad on how raising child with Angelman syndrome changed him

9 days ago

Novo Nordisk's Wegovy pill launch draws a new wave of patients into GLP-1s

10 days ago

Trump admin finalizes better-than-feared Medicare Advantage payment rate

12 days ago

FDA declines to issue specific guidance on health programs' foreign drug imports

13 days ago

Trump administration sets up to 100% tariffs on some imported drugs

13 days ago

Novo Nordisk says Wegovy pill outperforms Lilly's oral GLP-1 in cross-trial comparison

17 days ago

Eli Lilly opposes White House push to codify most favored nation drug pricing

17 days ago

FDA approves Eli Lilly's GLP-1 pill, opening next phase for weight loss drugs

18 days ago

Stocks soar on hopes of war resolution — plus, Lilly takes a swing in sleep disorders

18 days ago

Lilly to spend up to $7.8 billion to acquire Centessa, sleep disorder drugmaker

19 days ago

Novo Nordisk launches Wegovy subscriptions as it tries to catch up with Eli Lilly

19 days ago

Eli Lilly reaches deal to bring AI-developed drugs to global market

19 days ago

AstraZeneca stock jumps after surprise lung disease trial win

21 days ago

Pfizer to seek approval for Lyme disease vaccine candidate despite trial miss

23 days ago

Danone to buy protein shake maker Huel as health nutrition craze drives demand shift

27 days ago

The price of menstrual products is skyrocketing from inflation, tariffs

28 days ago

GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up

29 days ago

How CNBC Cures is bringing rare disease stories to a national audience

30 days ago

FDA approves higher-dose version of Novo Nordisk's obesity drug Wegovy

30 days ago

9% of ACA health-care plan enrollees uninsured after enhanced subsidies expire: Poll

1 month ago

Eli Lilly's obesity drug retatrutide clears first late-stage diabetes trial

1 month ago

Stopping GLP-1s raises risk of heart attack, stroke and death, study says

1 month ago

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

1 month ago